A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors


Yazici Y., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES, vol.66, no.1, pp.124-127, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1136/ard.2006.055848
  • Title of Journal : ANNALS OF THE RHEUMATIC DISEASES
  • Page Numbers: pp.124-127

Abstract

Background: The adequacy of reporting the time element in adverse effects in articles on randomised clinical trials of cyclooxygenase-2 and tumour necrosis factor (TNF) a antagonists was surveyed.